TechNavio's analysts forecast the Global Life Science and Chemical Instrumentation market to grow at a CAGR of 8.64 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rapid technological developments in the Diagnostics industry. The Global Life Science and Chemical Instrumentation market has also been witnessing an increasing number of outsourcing activities. However, the intense competition among vendors could pose a challenge to the growth of this market.
TechNavio's report, Global Life Science and Chemical Instrumentation Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it covers the Global Life Science and Chemical Instrumentation market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space are Roche Holding Ltd., Thermo Fischer Scientific Inc., Life Technologies Corp., and Agilent Technologies Inc.
The other vendors mentioned in the report are Danaher Corp., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Affymetrix Inc., GE Healthcare Ltd., Perkin Elmer Inc., Siemens Healthcare, Abbott Laboratories, Hitachi High-technologies Corp., RainDance Technologies Inc., Tecan Group Ltd., Eppendorf AG, Oxford Nanopore Technologies Ltd., and Genia Corp.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of each of these key vendors?
01. Executive Summary
03. Market Coverage
04. Market Landscape
04.1. Market Size and Forecast
04.2. Market Segmentation
04.3. Global Spectrometry Market
04.4. Global DNA Sequencer Market
04.5. Global Flow Cytometry Market
04.6. Global Microarray Market
04.7. Global Electrophoresis Market
04.8. Five Force Analysis
05. Geographical Segmentation
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1. Roche Holding Ltd.
13.1.1. Business Overview
13.1.2. Key Information
13.1.3. SWOT Analysis
13.2. Thermo Fischer Scientific Inc.
13.2.1. Business Overview
13.2.2. Business Segmentation
13.2.3. Key Information
13.2.4. SWOT Analysis
13.3. Life Technologies Corp.
13.3.1. Business Overview
13.3.2. Key Information
13.3.3. SWOT Analysis
13.4. Agilent Technologies Corp.
13.4.1. Business Overview
13.4.2. Business Segmentation
13.4.3. Key Information
13.4.4. SWOT Analysis
14. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Life Science and Chemical Instrumentation Market 2012–2016 (US$ billion)
Exhibit 2: Global Life Science and Chemical Instrumentation Market Segmentation
Exhibit 3: Global Life Science and Chemical Instrumentation Market Segmentation 2012
Exhibit 4: Global Spectrometry Market 2012-2016 (US$ billion)
Exhibit 5: Global DNA Sequencer Market 2012-2016 (US$ billion)
Exhibit 6: Global Flow Cytometry Market 2012-2016 (US$ million)
Exhibit 7: Global Microarray Market 2012-2016 (US$ billion)
Exhibit 8: Global Electrophoresis Market 2012-2016 (US$ billion)
Exhibit 9: Global Life Science and Chemical Instrumentation Market by Geographical Segmentation 2012
Exhibit 10: Global Life Science and Chemical Instrumentation Market by Vendor Segmentation 2012
Exhibit 11: Business Segmentation of Roche Holding Ltd.
Exhibit 12: Business Segmentation of Thermo Fisher Scientific Inc.
Exhibit 13: Business Segmentation of Life Technologies Corp.
Exhibit 14: Business Segmentation of Agilent Technologies Inc.